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Background: Idiopathic systemic capillary leak syndrome (ISCLS) is a rare disorder, characterized by episodic
life-threatening hypotension, hypoalbuminemia, and hemoconcentration.
Case presentation: A 10-year-old girl presented with abdominal pain, vomiting, diarrhea, fever and developed
generalized edema a day after admission. Clinical and laboratory findings were consistent with ISCLS. She received
aggressive fluid replacement, methylprednisolone pulse (30 mg/kg/day), high-dose intravenous immunoglobulin
(IVIG, 2 g/kg/day) and plasma exchange in acute phase. She received fasciotomy of bilateral lower extremities as
she developed complications of compartment syndrome. Since there were two episodes of ISCLS attacks,
theophylline and terbutaline were initiated for prevention of attacks and then the remission is currently maintained.
Because of high fatality rate in ISCLS, prompt diagnosis and intervention are very important.
Conclusion: We describe here, a rare case of pediatric ISCLS. ISCLS should be considered as a differential diagnosis,
when the patient presents with unexplained or sudden hypovolemic shock. Reports on pediatrics ISCLS are very
few, and accumulation of similar case reports is needed.
Keywords: Idiopathic systemic capillary leak syndrome, Vascular endothelial damage, Methylprednisolone pulse,
Theophylline, TerbutalineBackground
Idiopathic Systemic Capillary Leak Syndrome (ISCLS),
also known as Clarkson’s disease, is a very rare disorder,
characterized by recurrent episodes of severe hypotension,
hypoalbuminemia and hemoconcentration [1]. Attacks of
ISCLS demonstrate three phases: (1) prodrome, (2) hypo-
volemia with weight gain and (3) hypervolemia with fluid
overload and polyuria often complicated by pulmonary
edema. Compartment syndrome, leading to rhabdomyoly-
sis is a serious complication of ISCLS [2].
Case presentation
A 10-year-old girl; previously healthy, and with an unre-
markable clinical history, presented with abdominal pain,
diarrhea and the axillary temperature was 37.6°C. She
had no pruritus. She consulted a clinic with hypotension,
tachycardia (156 beats/minute) and somnolence tendency.* Correspondence: masaru@clin.medic.mie-u.ac.jp
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reproduction in any medium, provided the orRapid fluid infusion was administered immediately, and
blood pressure was recovered to 120/68 mmHg in fifteen
minutes. She was later transferred to a local hospital
where she received rapid infusion (0.3 L per hour) as sys-
tolic blood pressure was 40 mmHg. Since hypovolemic
shock was suspected, she was transferred to our hospital.
She had somnolence tendency and pallor, with blood
pressure 100/60 mmHg, tachycardia (180 beats/minute),
fever (38.1°C) and body weight 34.3 kg (34.0 kg before ad-
mission). Laboratory data indicated hemoconcentration,
hypoalbuminemia, renal dysfunction, leukocytosis and ele-
vated C-reactive protein (Table 1). Arterial blood gas ana-
lysis showed metabolic acidosis. Urinalysis on admission
revealed proteinuria. It was transient because the following
urinalysis revealed no proteinuria. Chest X-ray demon-
strated cardio-thoracic ratio 45% with no pleural effusion.
Antibiotics were administered on suspicion of bacterial
infection. Echocardiography revealed modest pericar-
dial effusion with ejection fraction of 50%. Computedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Laboratory data on admission
WBC 41 × 103/μL (3.9-6.60 × 103/μL) C1-INH 150% (70–130%)
RBC 7.99 × 106/μL (4.08-4.81 × 106/μL) C3 23.6 IU/L (65.0-141.0 IU/L)
Hb 23.3 g/dl (12.0-14.7 g/dl) C4 6.1 IU/L (13.0-40.0 IU/L)
Ht 64.4% (37.0-44.6%) CH50 15.1 IU/L (31–48 IU/L)
PLT 25.7 × 104/μL (18.0-36.5 × 104/μL) ANA <40 (<40)
VEGF <20 pg/ml (<20 pg/ml)
IL-6 85.8 pg/ml (<420 pg/ml)
Alb 2.3 g/dL (3.5-5.0 g/dL) G-CSF 217 pg/ml (<39 pg/ml)
BUN 42 mg/dL (8–20 mg/dL)
CRE 2.1 mg/dL (0.42-0.68 mg/dL) Urinalysis
Na 130 mEq/L (135–145 mEq/L) protein 100 mg/dL
K 4.8 mEq/L (3.3-5.0 mEq/L) blood 3+
Cl 98 mEq/L (96–109 mEq/L) RBC >100 /HPF
Ca 7.6 mg/dL (8.5-10.5 mg/dL) Bence-Jones Protein (−)
CPK 399 U/L (12–170 U/L)
CRP 3.24 mg/dL (0–0.30 mg/dL) Culture (Blood, Urine, Stool): (−)
C1-INH: C1-esterase inhibitor, ANA: antinuclear antibody, VEGF: vascular endothelial growth factor IL-6, G-CSF: granulocyte colony-stimulating factor.
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testinal dilatation. Because systolic blood pressure had
decreased to 50 mmHg, she received massive infusion
(saline solution), albumin, fresh frozen plasma and
vasopressor (dopamine). On day 1 systolic blood pres-
sure could be maintained at 70 to 90 mmHg. CT was
performed again and demonstrated the pleural effusion
and abdominal distension with massive ascites. She was
intubated and received mechanical ventilation. On day
2 she developed severe hypoalbuminemia (1.8 g/dl) and
weight gain (40.7 kg). Severe ISCLS was suspected. She
received methylprednisolone (30 mg/kg/day), high-
dose IVIG (2 g/kg/day) and plasma exchange. Because
she presented with the oliguria (300 mL/day) and
hyperkalemia (6.6 mEq/L) by acute renal failure, con-
tinuous hemodiafiltration (CHDF) was started. She had
complications of compartment syndrome of lower ex-
tremities, which led to rhabdomyolysis. Therefore she
underwent fasciotomy. On day 3 hemodynamic state
was stable and serum albumin level was maintained at
or above 2.5 mg/dL. Interleukin (IL) -6 and granulocyte
colony-stimulating factor (G-CSF) were elevated in
plasma (Shown in Table 1). Vascular endothelial growth
factor (VEGF) was normal in plasma, but was elevated
in ascites. Since she had second attack of ISCLS on day
26, combined prophylactic therapy with terbutaline and
theophylline was initiated for prevention. She had anuria
(20–80 ml/day) for 55 days and subsequently urine output
was gradually increased. She was discharged with having
mild sensory and motor disturbance of lower extremities.
Currently, she is healthy without episodes of ISCLS attack
during follow-up for over 1 year.Conclusions
Only 10 cases of ISCLS in children have been reported to
date [3-11]. These attacks occurred at ages ranging from
5 months to 8 years. Most of the cases were severe or fatal.
All patients in reports were previously healthy and only
one had a family history of ISCLS. ISCLS should be in-
cluded in the differential diagnosis of sudden hypovolemic
shock with general edema (anaphylaxis, C1-esterase in-
hibitor deficiency, nephrotic syndrome). Pathogenesis and
pathophysiology of ISCLS are relatively unknown. Reports
suggest that VEGF and angiopoietin 2 (Ang2) contribute
to endothelial contraction and might be associated with
pathogenesis [12]. Elevated levels of cytokines and chem-
ical mediators (G-CSF, IL-6, IL-8 and monocyte chemo-
tactic protein-1: MCP-1) were reported in some cases
[13]. G-CSF and VGEF levels might be a used as bio-
markers for the severity and for monitoring the clinical
course in ISCLS [14,15]. In the present case, G-CSF was
elevated, but VEGF was normal in plasma. Surprisingly,
VEGF in ascites was elevated. There was a case report that
did not show increase of VEGF in plasma as the present
case, but the reason is unknown [16]. Further investiga-
tions of various biomarkers, which might play an import-
ant role, are needed for clarify the pathophysiology of
ISCLS. Although there are no established therapies in
acute phase, corticosteroids and IVIG has been used to
treat ISCLS attacks [8,17]. Recently, it has been reported
that a patient with ISCLS after stem cell transplantation
was received anti-VEGF antibody bevacizumab despite
low serum VEGF level, and improved within 48 hours
[16]. In pediatric case, the tumor necrosis factor alpha
(TNF-α) antagonist infliximab was administered when
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veloped dramatically [6]. In present case, methylpredniso-
lone and IVIG could not improve symptoms and the
effect of these treatments was limited. Therefore, appro-
priate fluid management in acute phase is most important.
Prophylactic treatment with theophylline and terbutaline
as well as IVIG has been shown to reduce frequency and
severity of ISCLS attacks, which could be effective in the
present case [8,18].
In conclusion, ISCLS should be considered in the differ-
ential diagnosis when unexplained hypovolemic shock is
observed. The diagnostic evaluation should be performed
concurrently with initial fluid management. Immediate
intervention should be started because ISCLS has a high
fatality rate.
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